Latest Breaking News On - Long term tolerability - Page 1 : comparemela.com

Zynerba Pharma (ZYNE) Presents Positive Data from Phase 2 INSPIRE Trial

Zynerba Pharma (ZYNE) Presents Positive Data from Phase 2 INSPIRE Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Peter vozzoSociety for the study of behavioural phenotypesExchange commissionZynerba pharmaceuticals incInternational research symposiumEuropean commissionDrug administrationChild health research centreZynerba pharmaceuticalsUniversity of queenslandEuropean medicines agencyBehavioural phenotypesAssociate professorOpen label trial assessingLong term tolerabilityTransdermal gel

Zynerba Pharmaceuticals Announces Podium and Poster Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

DEVON, Pa., May 23, 2023 Zynerba Pharmaceuticals, Inc. , the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today. | May 23, 2023

United statesMiami beachPeter vozzoZynerba pharmaceuticalsDrug administrationZynerba pharmaceuticals incAmerican society of clinical psychopharmacology annual meetingEuropean medicines agencyExchange commissionAmerican societyClinical psychopharmacology annual meetingOpen label trial assessingLong term tolerabilityTransdermal gelLong term safetySustained efficacy